Gene surgery
| dc.contributor.author | El-Kenawy, Ayman | |
| dc.contributor.author | Benarba, Bachir | |
| dc.contributor.author | Neves, Adriana Freitas | |
| dc.contributor.author | de Araujo, Thaise Gonçalves | |
| dc.contributor.author | Ling, Tan Bee | |
| dc.contributor.author | Gouri, Adel | |
| dc.date.accessioned | 2020-05-20T13:30:28Z | |
| dc.date.available | 2020-05-20T13:30:28Z | |
| dc.date.issued | 2019-10-11 | |
| dc.description.abstract | Gene therapy became in last decade a new emerging therapeutic era showing promising results against different diseases such as cancer, cardiovascular diseases, diabetes, and neurological disorders. Recently, the genome editing technique for eukaryotic cells called CRISPR-Cas (Clustered Regulatory Interspaced Short Palindromic Repeats) has enriched the field of gene surgery with enhanced applications. In the present review, we summarized the different applications of gene surgery for treating human diseases such as cancer, diabetes, nervous, and cardiovascular diseases, besides the molecular mechanisms involved in these important effects. Several studies support the important therapeutic applications of gene surgery in a large number of health disorders and diseases including β-thalassemia, cancer, immunodeficiencies, diabetes, and neurological disorders. In diabetes, gene surgery was shown to be effective in type 1 diabetes by triggering different signaling pathways. Furthermore, gene surgery, especially that using CRISPR-Cas possessed important application on diagnosis, screening and treatment of several cancers such as lung, liver, pancreatic and colorectal cancer. Nevertheless, gene surgery still presents some limitations such as the design difficulties and costs regarding ZFNs (Zinc Finger Nucleases) and TALENs (Transcription Activator-Like Effector Nucleases) use, off-target effects, low transfection efficiency, in vivo delivery-safety and ethical issues. | en |
| dc.identifier.issn | 1611-2156 | |
| dc.identifier.uri | http://hdl.handle.net/2003/39120 | |
| dc.identifier.uri | http://dx.doi.org/10.17877/DE290R-21038 | |
| dc.language.iso | en | |
| dc.relation.ispartofseries | EXCLI Journal;Vol. 18 2019 | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | Gene surgery | en |
| dc.subject | CRISPR-Cas | en |
| dc.subject | Cancer | en |
| dc.subject | Diabetes | en |
| dc.subject | Obesity | en |
| dc.subject.ddc | 610 | |
| dc.title | Gene surgery | en |
| dc.title.alternative | potential applications for human diseases | en |
| dc.type | Text | |
| dc.type.publicationtype | article | |
| dcterms.accessRights | open access | |
| eldorado.dnb.zdberstkatid | 2132560-1 |